CERTIFICATION OF ENROLLMENT
SUBSTITUTE SENATE BILL 6086
66TH LEGISLATURE
2020 REGULAR SESSION
Passed by the Senate February 14, 2020
  Yeas 47  Nays 0

President of the Senate
Passed by the House March 6, 2020
  Yeas 97  Nays 0

Speaker of the House of Representatives
CERTIFICATE
I, Brad Hendrickson, Secretary of the Senate of the State of Washington, do hereby certify that the attached is SUBSTITUTE SENATE BILL 6086 as passed by the Senate and the House of Representatives on the dates hereon set forth.

Secretary
Secretary
Approved
FILED
Secretary of State
State of Washington

SUBSTITUTE SENATE BILL 6086

Passed Legislature - 2020 Regular Session
State of Washington
66th Legislature
2020 Regular Session
BySenate Behavioral Health Subcommittee to Health & Long Term Care (originally sponsored by Senators Hasegawa, Keiser, Kuderer, and Nguyen)
READ FIRST TIME 02/03/20.
AN ACT Relating to increasing access to medications for people with opioid use disorder; adding a new section to chapter 18.64 RCW; and creating a new section.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF WASHINGTON:
NEW SECTION.  Sec. 1. (1) The legislature declares opioid use disorder is a public health crisis. Access to medications to treat this disease needs to be made readily available, especially to vulnerable populations who may not be able to access medical care or a pharmacy.
(2) The legislature recognizes that increased access to buprenorphine, as well as additional medications necessary to aid in recovery, could benefit individuals who are suffering from opioid use disorder. The legislature further recognizes that access to pharmacies may be difficult for vulnerable populations. To increase access to medications while ensuring patient safety the legislature intends to create a new credential to allow for a pharmacy license to be extended to a remote dispensing site where technology is used to dispense medications.
NEW SECTION.  Sec. 2. A new section is added to chapter 18.64 RCW to read as follows:
(1) The license of location for a pharmacy licensed under this chapter may be extended to a remote dispensing site where technology is used to dispense medications approved by the United States food and drug administration for the treatment of opioid use disorder.
(2) In order for a pharmacy to use remote dispensing sites, a pharmacy must register each separate remote dispensing site with the commission.
(3) The commission shall adopt rules that establish minimum standards for remote dispensing sites registered under this section. The minimum standards shall address who may retrieve medications for opioid use disorder stored in or at a remote dispensing site pursuant to a valid prescription or chart order. The minimum standards must require the pharmacy be responsible for stocking and maintaining a perpetual inventory of the medications for opioid use disorder stored in or at the registered remote dispensing site.
(4) The secretary may adopt rules to establish a reasonable fee for obtaining and renewing a registration issued under this section.
(5) The registration issued under this section will be considered as part of the pharmacy license issued under RCW 18.64.043. If the underlying pharmacy license is not active, then the registration shall be considered inoperable by operation of law.
--- END ---